Home / Journals / CJU / Vol.30, No.4, 2023
Special Issues
  • Open AccessOpen Access

    EDITORIAL

    The Bladder and the Bowel: More Than Just Neighbors

    Leonard G. Gomella
    Canadian Journal of Urology, Vol.30, No.4, pp. 11583-11583, 2023
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    BOOK REVIEW

    Andrology and Sexual Medicine

    Selcuk Sarikaya
    Canadian Journal of Urology, Vol.30, No.4, pp. 11584-11584, 2023
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    LEGENDS IN UROLOGY

    LEGENDS IN UROLOGY

    Don Lamm
    Canadian Journal of Urology, Vol.30, No.4, pp. 11585-11587, 2023
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    REVIEW

    Emergence of artificial generative intelligence and its potential impact on urology

    Mohamed Javid1, Madhu Reddiboina2, Mahendra Bhandari3
    Canadian Journal of Urology, Vol.30, No.4, pp. 11588-11598, 2023
    Abstract Introduction: Artificial generative intelligence (AGI) and large language models (LLMs) have gained significant attention in healthcare and hold enormous promise for transforming every aspect of our life and urology is no exception.
    Materials and methods: We conducted a comprehensive literature search of electronic databases and included articles discussing AGI and LLMs in healthcare. Additionally, we have incorporated our experiences interacting with the ChatGPT and GPT-4 in different situations with real case reports and case constructs.
    Results: Our review highlights the potential applications and likely impact of these technologies in urology, for differential diagnosis, prioritizing treatment options, and facilitating… More >

  • Open AccessOpen Access

    ARTICLE

    Less is more: single dose versus extended antibiotic prophylaxis for transperineal prostate biopsy

    Maxwell Sandberg1, Wyatt Whitman1, Janmejay Hingu1, Parth Thakker1, Anita Rong2, Caleb Bercu2, Jacob Greenberg3, Ronald Davis III1, Ashok Hemal1, Matvey Tsivian1
    Canadian Journal of Urology, Vol.30, No.4, pp. 11599-11604, 2023
    Abstract Introduction: There is an ongoing debate as to the appropriate regimen of antibiotic prophylaxis with transperineal (TP) biopsy. The objective of this study was to report the rate of infection following TP biopsy at a high-volume institution and assess the impact of single dose antibiotics at the time of biopsy versus outpatient antibiotics in preventing postprocedural infections.
    Materials and methods: Records of men undergoing TP prostate biopsy from 2012 to 2022 were reviewed. Patients were divided into two groups, those who received single dose intravenous (IV) antibiotics at the time of biopsy (n = 440) and those… More >

  • Open AccessOpen Access

    COMMENTARY

    Re: Less is more: single dose versus extended antibiotic prophylaxis for transperineal prostate biopsy

    Roderick Clark, Jay D. Raman
    Canadian Journal of Urology, Vol.30, No.4, pp. 11605-11606, 2023
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    ARTICLE

    A preliminary report assessing the feasibility and effectiveness of amniotic bladder therapy in patients with chronic radiation cystitis

    Codrut Radoiu1, Julian Jeberaeel1, Raghav Madan1, Nitin Vaishampayan1,2, Steve Lucas1,3, Alaa Hamada3, Nivedita Dhar3,4
    Canadian Journal of Urology, Vol.30, No.4, pp. 11607-11612, 2023
    Abstract Introduction: Chronic radiation cystitis (CRC) can develop between 6 months and 20 years after radiation therapy that presents with symptoms of urinary frequency, urgency, bladder pain, and nocturia. Amniotic membrane (AM) is known to contain pro-regenerative properties and could thereby be a potential therapeutic modality for radiation-induced tissue injury of the bladder.
    Materials and methods: CRC patients recalcitrant to previous treatments received amniotic bladder therapy (ABT) comprised of intra-detrusor injections of 100 mg micronized AM (Clarix Flo) diluted in 10 mL 0.9% preservative-free sodium chloride. Clinical evaluation and questionnaires (Interstitial Cystitis Symptom Index (ICSI), Interstitial Cystitis Problem… More >

  • Open AccessOpen Access

    ARTICLE

    Attitudes towards disposition of cryopreserved sperm in the event of death

    Dylan Buller1, Brooke Harnisch1, Vikram Lyall2, Michael Goltzman1, Evelyn Neuber3, Alison Bartolucci3, Stanton Honig1,4
    Canadian Journal of Urology, Vol.30, No.4, pp. 11613-11618, 2023
    Abstract Introduction: To evaluate patient preference for sperm disposition in case of death based on demographic factors and infertility etiology.
    Materials and methods: This retrospective cohort study was performed at a university hospital-affiliated fertility center. Charts of 550 men undergoing cryopreservation for assisted reproductive technologies (ART) between 2016-2019 were reviewed to create a descriptive dataset. Patients previously signed consent forms stating their preference for sperm transfer to their partner or disposal in the event of their subsequent death. Patients undergoing sperm cryopreservation for the purpose of ART were analyzed to assess associations between demographic characteristics and etiology of… More >

  • Open AccessOpen Access

    ARTICLE

    Improvement in International Prostate Symptom Score after prostatic urethral lifts is dependent on prostatic volume

    Sagar R. Patel, Katherine A. Lowrey, Angeline Johny, Christopher P. Smith
    Canadian Journal of Urology, Vol.30, No.4, pp. 11619-11623, 2023
    Abstract Introduction: Prostatic urethral lifts (PUL) provide improvement in urinary symptoms for men with benign prostatic hyperplasia (BPH). The aim of this study is to determine operative factors associated with improvement in urinary symptoms after PUL in men with bothersome BPH.
    Materials and methods: Men with BPH undergoing PUL at a single, tertiary center were identified from 2019 to 2022. Inclusion criteria included documented prostate volume as well as preoperative and postoperative cystoscopic images of the prostatic urethra. Multivariate regression modeling was performed to determine the predictive factors—including prostate volume, number of implants, and degree of unobstructed prostatic… More >

  • Open AccessOpen Access

    ARTICLE

    Proposal to decrease incidence, morbidity, and associated healthcare costs regarding difficult and traumatic urethral catheterization – a protocol for DMC hospitals: A pilot study

    Jordan Sarver, Remington Farley, Shane Daugherty, Jordan Bilbrew, Joshua Palka
    Canadian Journal of Urology, Vol.30, No.4, pp. 11624-11628, 2023
    Abstract Introduction: Difficult and traumatic urethral catheterization is a common reason for urologic consult. Catheter insertion and management is common for patients who are managed in the hospital setting.
    Materials and methods: A four-question survey was distributed across three hospitals at a single-institution.
    Results: A total of 41 nursing staff responses were recorded. Forty-four percent of the nursing staff reported prior participation in a traumatic catheter insertion. Ninety percent of total responders reported a prior involvement with a difficulty catheter.
    Conclusion: Patient morbidity and healthcare costs regarding traumatic and difficult catheterization is significant. Utility of protocols and education could potentially More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Calyceal diverticulum simulating a renal tumor

    Joaquin Fernandez-Alberti1, Ramon Coronil2, Alejandro Iotti3, Alejandro Nolazco1, Marcelo Featherston1
    Canadian Journal of Urology, Vol.30, No.4, pp. 11629-11632, 2023
    Abstract Calyceal diverticulum (CD) is a rare anatomic anomaly with an incidence of 0.2% to 0.6% in the patients undergoing renal imaging. They are considered benign lesions and malignancy is exceedingly rare. For diagnosis it is suggested to perform a multiphasic contrast-enhanced computed tomography (CT) evidencing a diverticulum of the pelvicalyceal system with thin-walled cavities communicating with the central collecting system. However, they can be usually mistaken as kidney cancers leading to unjustified nephrectomy. Here, we present a case of a 34-year-old patient who underwent surgery in 2022 due to suspected kidney cancer and histopathological analysis More >

  • Open AccessOpen Access

    HOW I DO IT

    How I Do It: Maintenance avelumab for advanced urothelial carcinoma

    Aly-Khan A. Lalani
    Canadian Journal of Urology, Vol.30, No.4, pp. 11633-11638, 2023
    Abstract For more than four decades, platinum-based chemotherapy regimens have served as the established standard-of-care for advanced urothelial carcinoma (aUC). However, advancements in our understanding of cancer biology and tumor microenvironment have reshaped the therapeutic landscape and prognosis of this incurable disease. Immune checkpoint inhibitors (ICIs) that target programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) are firmly established tools in aUC management, leading to enhanced life span and improved quality of life for patients.
    In patients who achieved stable disease or better following platinum-based chemotherapy, maintenance therapy with the PD-L1 antibody… More >

  • Open AccessOpen Access

    HOW I DO IT

    How I Do It: ERAS protocol featuring erector spinae plane block for percutaneous nephrolithotomy

    Bertie Zhang1, Arinze J. Ochuba2, Gregory R. Mullen3, Arun Rai3, Tareq Aro3, David M. Hoenig3, Zeph Okeke3, Jared S. Winoker1,3
    Canadian Journal of Urology, Vol.30, No.4, pp. 11639-11643, 2023
    Abstract Percutaneous nephrolithotomy (PCNL) is the gold-standard treatment for large and complex renal stones. Though associated with higher stone-free rates compared to other minimally invasive stone procedures, this comes at the expense of increased morbidity including postoperative pain and discomfort. We describe our enhanced recovery after surgery (ERAS) protocol for PCNL with emphasis on the use of erector spinae plane blocks to improve patient satisfaction and reduce postoperative opioid use and bother. More >

Per Page:

Share Link